Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Model of diastolic dysfunction with preserved ejection fraction developed to test HDAC6 inhibition

July 6, 2021

Alnylam initiates phase II study of zilebesiran for mild to moderate hypertension

June 30, 2021

Loss-of-function mutations in IPO8 lead to syndromic thoracic aortic aneurysm

June 30, 2021

First patients enrolled in IMPROVE-DiCE study of IMB-101

June 23, 2021

Sirtuin affects cardiac lipotoxicity via secondary mechanism

June 15, 2021

IMDC recommends continuation of phase IIb study of nangibotide in septic shock

June 10, 2021

InCarda announces progress in development program for InRhythm

June 10, 2021

Arena begins phase II study of temanogrel for coronary microvascular obstruction

June 9, 2021

Epeleuton shows efficacy in preclinical models of atherosclerosis

June 3, 2021

ATTR removal observed in vitro and in vivo with NI-006

June 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...